Japan mobilised military doctors and nurses to give shots to elderly people in Tokyo and Osaka on Monday as the government desperately tries to accelerate its vaccination rollout and curb coronavirus infections just two months before hosting the Olympics.
Prime Minister Yoshihide Suga is determined to hold the Olympics in Tokyo after a one-year delay and has made an ambitious pledge to finish vaccinating the country's 36 million elderly people by the end of July, despite scepticism it's possible.
Worries about public safety while many Japanese remain unvaccinated have prompted growing protests and calls for cancelling the Games set to start on July 23.
Suga's government has repeatedly expanded the area and duration of a virus state of emergency since late April and has made its virus-fighting measures stricter. But with COVID-19 cases still persistently high, Suga says vaccines are key to getting the infections under control.
At the two mass inoculation centres staffed by Japan's Self-Defence Forces, the aim is to inoculate up to 10,000 people per day in Tokyo and another 5,000 per day in Osaka for the next three months.
People inoculated at the centres on Monday were the first in Japan to receive doses from Moderna Inc, one of two foreign-developed vaccines Japan approved on Friday.
Previously Japan had used only Pfizer Inc, and only about 2% of the population of 126 million has received the required two doses.
Japan began vaccinating health care workers in mid-February while sticking to a standard requirement of clinical testing inside Japan a decision many experts said was statistically meaningless and only caused delay.
Vaccinations for the next group the elderly, who are more likely to suffer serious COVID-19 effects started in mid-April but has been slowed by bureaucratic bumbling including reservation procedures, unclear distribution plans and shortage of medical staff to give shots.
Completion of Japan-developed vaccines is still uncertain, but Japanese government officials hope the approvals Friday of Moderna and AstraZeneca will help speed up the rollout.
Progress is still unclear because of the dire shortage of medical staff who can give shots while they are already busy treating COVID-19 patients. AstraZeneca's plans are also pending due to concerns about its rare blood-clotting in a country known for low confidence in vaccines.
Separately, several local governments, including Aichi in central Japan and Gunma near Tokyo and Miyagi in the north, were also to open their own large vaccination centres on Monday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor